Compile Data Set for Download or QSAR
maximum 50k data
Found 15 with Last Name = 'moji' and Initial = 'm'
TargetMetallo-beta-lactamase VIM-2(Pseudomonas aeruginosa (g-Proteobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153698(L-CS319)
Affinity DataKi:  3.70E+3nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
TargetMetallo-beta-lactamase VIM-2(Pseudomonas aeruginosa (g-Proteobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153700(L-VC26)
Affinity DataKi:  3.80E+3nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVIM-24(Klebsiella pneumoniae (Enterobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153700(L-VC26)
Affinity DataKi:  4.90E+3nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMetallo-beta-lactamase VIM-2(Pseudomonas aeruginosa (g-Proteobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153699(D-CS319)
Affinity DataKi:  5.40E+3nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVIM-24(Klebsiella pneumoniae (Enterobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153698(L-CS319)
Affinity DataKi:  6.00E+3nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
TargetVIM-24(Klebsiella pneumoniae (Enterobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153699(D-CS319)
Affinity DataKi:  1.10E+4nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVIM-24(Klebsiella pneumoniae (Enterobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153701(D-VC26)
Affinity DataKi:  1.20E+4nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMetallo-beta-lactamase VIM-2(Pseudomonas aeruginosa (g-Proteobacteria))
Louis Stokes Cleveland Veterans Affairs Medical Center

LigandPNGBDBM153701(D-VC26)
Affinity DataKi:  1.40E+4nMAssay Description:The Ki for each inhibitor was determined by direct competition assays under steady-state conditions. The initial velocity was measured in the presenc...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138390(US8877786, Example 3-1)
Affinity DataIC50:  0.0900nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138396(US8877786, Example 3-13)
Affinity DataIC50:  0.200nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138395(US8877786, Example 3-12)
Affinity DataIC50:  0.200nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138391(US8877786, Example 3-2)
Affinity DataIC50:  0.300nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138393(US8877786, Example 3-7 | US8993631, 32-4)
Affinity DataIC50:  2.40nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138392(US8877786, Example 3-4)
Affinity DataIC50:  11nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeprilysin(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM138394(US8877786, Example 3-10)
Affinity DataIC50:  91nMpH: 7.4 T: 2°CAssay Description:The in vitro inhibition of recombinant human neutral endopeptidase (NEP, EC 3.424.11) can be determined as follows:Recombinant human neutral endopept...More data for this Ligand-Target Pair
In DepthDetails US Patent